Vanguard Group »

Kintara Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Kintara Therapeutics (KTRA) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Kintara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kintara Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kintara Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1k 13k 0.17
2023-09-30 $50k 13k 4.04
2022-12-31 $102k 15k 6.89

More positions owned by Vanguard Group

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Kintara Therapeutics

Nantahala Capital Management
Vanguard Group
Advisor Group Holdings
Wells Fargo & Company

View all funds holding Kintara Therapeutics